Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of PF-04447943 in mild to moderate Alzheimer's disease
2009-012179-82Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing PF-04447943 with Placebo (2 arms). Primary endpoint: ADAS-cog change at Week 12. Started Sep 2009; status: completed.
02
Drugs
edelinontrine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-012179-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012179-82.